Bone Cancer Clinical Trial
Official title:
Physical Characteristics of Retrieved Massive Allografts
This purpose of this study is to measure the strength of tissue allografts that have been in the body various lengths of time.
Allograft bone is the primary source of graft material for large skeletal defects resulting
from trauma, disease, oncological resection, or reconstruction of failed total joint
arthroplasties. The physical characteristics of such grafts after various intervals of
remodeling and incorporation in vivo have never been studied.
The purpose of this study is to obtain tissue from allografts retrieved at autopsy, at
amputation for oncological complications and from patients undergoing revision procedures
for failed allograft transplantation. We will evaluate the mechanical properties,
histomorphometric indices and presence of microfractures.
Our hypotheses are:
- histomorphometric parameters of porosity and microfracture density will predict
allograft strength,
- microfracture density will be correlated with time in vivo and allograft strength,
- the rate of host-allograft nonunion and fracture will correlate with radiation therapy
and chemotherapy.
The retrieved tissue will be processed using standard undecalcified histology and
quantitatively assessed for degree of incorporation, allograft porosity, and microfracture
density. The biomechanical characteristics of the bulk allograft and allograft-host junction
will be quantified and compared to allograft bone prior to transplantation.
;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03905174 -
Massive Implants the Next Generation
|
N/A | |
Completed |
NCT00160719 -
HLA Sensitization Following Major Cortical Allograft Bone Procedures
|
Phase 4 | |
Completed |
NCT04974008 -
Osteosarcoma Maintenance Therapy With OST31-164
|
Phase 2 | |
Not yet recruiting |
NCT06070259 -
Insights Into Participating in Studies for Bone Cancer
|
||
Completed |
NCT01553539 -
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
|
Phase 2 | |
Recruiting |
NCT03160274 -
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
|
||
Active, not recruiting |
NCT02880319 -
Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone
|
Phase 2 | |
Completed |
NCT01135849 -
B-Receptor Signaling in Cardiomyopathy
|
N/A | |
Terminated |
NCT00960063 -
A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)
|
Phase 1 | |
Terminated |
NCT02443103 -
Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis
|
N/A | |
Recruiting |
NCT04028479 -
The Registry of Oncology Outcomes Associated With Testing and Treatment
|
||
Terminated |
NCT03525392 -
Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.
|
Phase 1 | |
Terminated |
NCT01541358 -
Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer
|
N/A | |
Terminated |
NCT01313884 -
Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma
|
Phase 2 | |
Completed |
NCT01091883 -
Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma
|
N/A | |
Terminated |
NCT00127387 -
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT03106675 -
MR Imaging- Guided High Intensity Focused Ultrasound (HIFU) Therapy of Bone Metastases
|
N/A | |
Recruiting |
NCT05830084 -
Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma
|
Phase 1 | |
Completed |
NCT01085565 -
Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System
|
Phase 2 | |
Recruiting |
NCT04307914 -
Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases
|
N/A |